Primær hyperaldosteronisme Patienter med primær hyperaldosteronisme bør ikke behandles med angiotensin II- antagonisten, valsartan, da deres renin- angiotensin- system er påvirket af den primære lidelse.
15 Primary hyperaldosteronism Patients with primary hyperaldosteronism should not be treated with the angiotensin II antagonist valsartan as their renin-angiotensin system is affected by the primary disease.